Neuralia TMS Rolls Out New Tinnitus Treatment Options in Melbourne

Australia, 19th Aug 2025, - Neuralia TMS, a leading provider of innovative neuromodulation therapies, has announced the introduction of new treatment options for tinnitus, marking a significant step forward in the company's mission to offer effective, non-invasive therapies for neurological and psychiatric conditions. The new treatment options are now available at the clinic's Moonee Ponds location and are designed to provide lasting relief to individuals suffering from the debilitating effects of tinnitus, a condition that affects millions worldwide.

Neuralia TMS, renowned for its Transcranial Magnetic Stimulation (TMS) therapies, has expanded its treatment portfolio to include solutions for tinnitus, a condition that causes persistent ringing or buzzing in the ears. The new offerings combine advanced TMS techniques with tailored approaches to ensure optimal results for those affected by this challenging condition.

Dr. Shanek Wick, Medical Director at Neuralia TMS, commented on the expansion: "The decision to offer tinnitus treatment options at Neuralia TMS follows careful research and consideration into the effectiveness of TMS for addressing tinnitus. TMS therapy has proven beneficial for conditions such as depression, anxiety, and chronic pain. By adapting this therapy for tinnitus, the aim is to provide an effective, non-invasive solution for individuals who have struggled to find relief through traditional treatments."

Tinnitus can significantly impact an individual's quality of life, often leading to difficulties with sleep, concentration, and emotional well-being. Traditional treatment options, such as hearing aids and medications, offer limited relief for many individuals, which has led to an increased demand for alternative therapies. Neuralia TMS's new tinnitus treatment options utilise targeted neuromodulation to reduce the intensity of the auditory perception, offering a promising solution for those seeking non-drug interventions.

The clinic's approach to tinnitus treatment builds upon years of success in treating various neurological and psychiatric conditions using TMS. TMS works by using magnetic fields to stimulate specific areas of the brain, and recent studies have shown that it can have positive effects on tinnitus symptoms by modulating brain activity. The introduction of this new treatment aligns with Neuralia TMS’s ongoing commitment to providing cutting-edge therapies for a range of conditions.

Dr. Wick further elaborated on the broader vision: "Looking ahead, Neuralia TMS will continue to explore the potential of neuromodulation therapies, not just for tinnitus but also for other conditions that impact brain function. The ability to offer personalised treatment plans, tailored to each individual's unique genetic profile, combined with at-home neuromodulation options like tDCS, positions Neuralia TMS to continue making strides in the field of non-invasive therapy. As new research and technologies emerge, Neuralia TMS remains committed to improving patient outcomes through innovation and evidence-based treatments."

This expansion is part of Neuralia TMS’s ongoing efforts to diversify its offerings and enhance the effectiveness of its treatments. Patients who undergo TMS for tinnitus at Neuralia TMS will receive individualised care, with treatment plans designed to address their specific needs and conditions. The clinic’s use of cutting-edge technologies, including pharmacogenetic testing and tDCS therapy, ensures that every patient receives the most appropriate and effective care.

The new tinnitus treatment options are now available at Neuralia TMS’s Moonee Ponds clinic, located at Suite 102/149-155 Pascoe Vale Rd, Moonee Ponds 3039 VIC. Individuals interested in learning more about the tinnitus treatment Melbourne or scheduling a consultation are encouraged to contact the clinic directly at 03 9122 5246 or via email at info@neuralia.com.au.